Levocarnitine-induced hypophosphatemia in a hemodialysis patient with acute valproic acid toxicity

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 24, Issue 1, 2012, Pages

  Prohaska, Emily S ^a   Muzyk, D Andrew J ^a,b   Rivelli, D Sarah K ^c  

^a CAMPBELL UNIVERSITY   (United States)

^b DUKE UNIVERSITY   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM ACETATE; CARNITINE; CINACALCET; VALPROIC ACID;

ACUTE TOXICITY; ADULT; AFRICAN AMERICAN; BIPOLAR DISORDER; BRAIN DISEASE; CASE REPORT; DRUG OVERDOSE; DRUG WITHDRAWAL; FEMALE; HEMODIALYSIS PATIENT; HOSPITAL ADMISSION; HUMAN; HYPERPARATHYROIDISM; HYPOPHOSPHATEMIA; KIDNEY FAILURE; LETTER; PANCYTOPENIA; PRIORITY JOURNAL; WEAKNESS;

ADOLESCENT; ANTICONVULSANTS; BIPOLAR DISORDER; CARNITINE; DRUG TOXICITY; FEMALE; HUMANS; HYPOPHOSPHATEMIA; MIDDLE AGED; RENAL DIALYSIS; VALPROIC ACID; VITAMIN B COMPLEX;

EID: 84858732821     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.11010023     Document Type: Letter

References (5)

1. Lheureux PE, Hantson P: Carnitine in the treatment of valproic acid-induced toxicity. Clin Toxicol 2009; 47:101-111
2. Product Monograph. Carnitor (levocarnitine). Gaithersburg, MD: Sigma-Tau Pharmaceuticals, 2004; http://www.carnitor.com/downloads/VIFS_6.pdf (accessed Jan 22, 2011)
3. Ahmad S, Robertson HT, Golper TA, et al: Multicenter trial of L-carnitine in maintenance hemodialysis patients, II: clinical and biochemical effects. Kidney Int 1990; 38:912-918
4. Qazi RA, Martin KJ: Vitamin D in kidney disease: pathophysiology and the utility of treatment. Endocrinol Metab Clin North Am 2010; 39:355-363
5. Holick MF: Vitamin D deficiency. N Engl J Med 2007; 357:266-281